What to Know About Hidradenitis Suppurativa on the Breast
Hidradenitis suppurativa (HS) is a chronic skin condition where painful nodules (growth or lump) develop under your skin. If left untreated, HS can worsen and lead to the formation of skin tunnels and scarring.
Researchers estimate that HS may impact up to 1% of people worldwide.
It often develops on areas of the body where skin touches skin, such as the armpits, groin, and under the breasts. In some cases, it may also form on the breast.
Learn more about the symptoms of HS on the breast, as well as how it can be diagnosed and treated.
What are the symptoms?
In HS, deep nodules form under the skin that can often initially be mistaken for an acne cyst or a boil. At first, most people with HS only have one nodule in the affected area. However, more nodules can occur and recur as time passes.
People with HS typically develop one to two new lesions each month. You may feel a burning, itching, or painful sensation 12 to 48 hours before one forms.
Over time, HS nodules can become larger or join together, forming painful abscesses or tunnels under the skin. These may also break open and drain pus. Repeated breaking and healing of the skin can lead to scarring.
In rare cases, inflammation and scarring from HS can also cause a blockage in the lymphatic system, resulting in lymphedema. This has also been documented in HS on the breast. Lymphedema affecting the area of the breast can cause:
swelling or a feeling of heaviness in the breast, chest or arm
sensations of pain, itching, or numbness and tingling
skin changes like discoloration, thickening, or dryness
reduced range of motion that can affect daily activities
The effects of HS can also have a significant impact on quality of life. This can include things like poor quality sleep, challenges with daily activities, low self-confidence, and an increased risk of anxiety and depression.
How is it diagnosed?
A prompt diagnosis of HS of the breast is important. This is because treatment can help to ease symptoms and prevent new lesions from forming.
However, diagnosing HS can be challenging because it can look like other skin conditions, such as acne, boils, or cysts.
In order to diagnose HS on the breast, a healthcare professional will first get a thorough medical history. During this time, they'll ask about your lesions, when you first noticed them, and if they can be found anywhere else on your body.
They'll then do a careful examination of the skin of your breast to look for features characteristic of HS. Things they'll be looking for include:
deep nodules under your skin
abscesses
skin tunnels
scarring
They may also collect a sample of fluid from your lesions to test for an infection. They could also recommend breast imaging via mammogram, ultrasound, or MRI to help rule out other breast conditions.
What treatment options are available?
HS is typically treated with medications. However, surgical procedures may be suggested if your symptoms are severe.
Some HS medications are topical, meaning that you'll apply them directly to the skin of your breast. Topical medications are often used for milder HS and include the antibiotic clindamycin and resorcinol cream.
Some HS medications are given orally or by injection. This allows them to work throughout your body. Examples of such medications include:
In some situations, a procedure or surgery may be recommended to drain or to remove abscesses or tunnels. The extent of surgery can depend on how severe the lesions are.
It's also important to address anxiety or depression that's associated with HS. This can be done using medications, talk therapy, or a combination or both.
What lifestyle measures can help?
In addition to medications or procedures, there are many lifestyle measures that you can take to help with HS on the breast. These include:
avoiding squeezing, picking, or scrubbing at your skin, as this can lead to more irritation, inflammation, or infection
applying a warm compress to ease painful nodules
limiting sweating by using a mild antiperspirant, keeping living spaces cooler, and reducing physical activity in warm environments
ensuring that you wear undergarments and clothing that help to support your breasts
wearing looser, breathable clothing to prevent skin from rubbing together
taking steps to manage weight if you have overweight or obesity, including eating a healthy diet, which may help improve HS
quitting smoking, if you do smoke, as smoking can worsen HS symptoms
Most people with HS will need dressings at some point to cover lesions that are open or draining fluid. Be sure to carefully follow all wound care instructions provided by a healthcare professional.
Takeaway
HS is a chronic skin condition that can sometimes impact the breast. It can lead to painful nodules, abscesses, and tunnels under the skin as well as scarring.
A healthcare professional can diagnose HS on the breast based on a medical history and a skin exam that looks for characteristic signs of HS. Breast imaging may also be used to rule out other medical conditions affecting the breast.
HS is typically managed using lifestyle measures and medications, which may be topical, oral, or injected. Surgery may be recommended in severe situations. Timely diagnosis and treatment can help to improve outlook.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Why Centene (CNC) Stock Is Trading Up Today
What Happened? Shares of health coverage company Centene (NYSE:CNC) jumped 5.9% in the afternoon session after the company reported second-quarter results that missed earnings estimates, but the stock rallied as investors looked past the disappointment as sales came in ahead of expectations. Centene posted its first quarterly earnings miss in four years, swinging to an adjusted loss per share of $0.16, a stark contrast to the profit recorded in the same quarter last year. The company also set its 2025 earnings guidance significantly below analyst expectations, citing worse-than-expected cost trends in its Affordable Care Act (ACA) Marketplace business. Despite the profitability issues, total revenues for the quarter came in strong at $48.7 billion, handily beating expectations. While the stock initially dropped sharply in pre-market trading on the earnings miss, it reversed course and rallied during the company's earnings call. This turnaround suggested investors may have gained confidence from management's commentary and their stated plan to address the cost issues and restore profitability. Is now the time to buy Centene? Access our full analysis report here, it's free. What Is The Market Telling Us Centene's shares are somewhat volatile and have had 13 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 7 days ago when the stock dropped 3.9% as several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively. Additionally, some pharmaceutical and biotech companies experienced sharp drops following unfavorable news; for instance, Sarepta Therapeutics plunged after a report indicated another patient death tied to its experimental gene therapy, and GSK's blood cancer drug dosage was voted against by the FDA advisory committee. Broader market sentiment, including concerns about rising costs and inadequate pricing for 2025 plans among health insurers, also contributed to the downward pressure on healthcare equities. Centene is down 53.3% since the beginning of the year, and at $28.29 per share, it is trading 64.7% below its 52-week high of $80.23 from September 2024. Investors who bought $1,000 worth of Centene's shares 5 years ago would now be looking at an investment worth $420.47. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
Yahoo
24 minutes ago
- Yahoo
'It's The Craziest Gamble Ever,' Says Joe Rogan About Insurance. You Pay And Cross Your Fingers They'll Actually Cover You
Joe Rogan didn't hold back in a recent episode of his podcast when comedian Joe DeRosa joined him for a wide-ranging conversation that included the American healthcare system, specifically how insurance companies operate. Double Lung Surgery Denied Rogan told the story of former UFC and Bellator fighter Ben Askren, who at just 40 years old, needed a double lung transplant after suffering from necrotic pneumonia. 'He developed some kind of crazy pneumonia and then it became necrotic. So it like ate holes in his lungs,' Rogan said. 'He had to get a double lung replacement surgery at 40, and insurance didn't want to cover it.' Don't Miss: 7,000+ investors have joined Timeplast's mission to eliminate microplastics—now it's your turn to $100k+ in investable assets? – no cost, no obligation. DeRosa was floored, saying, 'It's insane.' Rogan went on to say Askren was on a ventilator for months, and despite his condition and history as a professional athlete, the insurance company refused to step up. Pay Every Month, Get Nothing? The conversation then turned to how insurance often feels like a scam. 'Their business is to pay you as little as possible and get you to give them money every month so that maybe if something happens, they'll pay for it. Maybe. But maybe not,' Rogan said. DeRosa compared it to a recent experience with home insurance after water damage in his condo. Even though it got covered, he still felt frustrated by the process. 'I can't f***ing imagine if you're in a situation like that where it's your health,' he said. Trending: Accredited Investors: Grab Pre-IPO Shares of the AI Company Powering Hasbro, Sephora & MGM— DeRosa took it one step further: 'Insurance has become buying the protection plan at Best Buy.' However, Rogan disagreed, saying, 'But no, Best Buy's protection plan is way better.' He explained that if, for example, your phone breaks, you just 'show your receipt, they shake your hand, thank you, and you leave. It's great!' He summed up the whole thing by calling it what it is: 'The insurance gamble is the craziest gamble ever. I'm going to pay you every month and hopefully you'll be kind enough to cover my insurance if something goes wrong.' A System That Feels 'Demonic' They also discussed the morality of insurance companies making life-and-death decisions based on cost. Asking what 'demonic behavior' would look like, Rogan had this to say: 'If you know that someone's going to die, but you can deny them coverage because you just can make some sort of subjective decision whether or not this person should get coverage, and then you know they're going to die and they've been paying for insurance for years. How do you do that?''That's like a pact,' he continued. 'Like, you could just sign here, and then they're covered, and then they get this operation. You do everything you can to help them, and then everybody loves your company. Or you could say, 'I just want the money now.' It's dark.' Ethics Are Optional Now The talk expanded to how more people, not just corporations, avoid accountability until they're forced to face it. 'People put themselves in a way where they say, 'I will not be accountable, and I will force you to be the one that has to hold me to something,'' DeRosa said. 'It makes me very, very sad.' Today, it often feels like personal and corporate ethics are treated as suggestions, not obligations. Read Next: Here's what Americans think you need to be considered 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article 'It's The Craziest Gamble Ever,' Says Joe Rogan About Insurance. You Pay And Cross Your Fingers They'll Actually Cover You originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten
Medscape
25 minutes ago
- Medscape
Medicare at 60: Successes, Failures
Sixty years ago, Congress passed legislation that created Medicare . In 1966, its first year of implementation, there were 19.1 million enrollees. Almost a decade later, enrollment had grown to 22.5 million. Today, 68.8 million Americans have Medicare coverage, with about half enrolled in Advantage plans. The original idea for this insurance program was even bigger, with President Harry Truman endorsing universal coverage in 1945. As Medicare turns 60, Medscape convened an expert panel to discuss the successes — and shortcomings — of this landmark insurance program. Jen Brull, MD: What do you all think the impact will be of the coming Medicaid cuts in the budget bill? For people who are dual eligible, who need help with shared costs, how do you think physicians might be affected if those patients lose access to Medicaid copays? Claudia M. Fegan, MD: The problem is that a lot of people think Medicaid cuts don't really affect me; I have private insurance. But as Norm alluded, there are going to be a lot of hospitals that close, especially rural hospitals. And as he said, when hospitals close, it puts stress on all the other hospitals that remain. And whether it's emergency room services or just services in general — women not having places to deliver babies — all of these things are going to have a tremendous impact. As for the dual-eligible patients, they are not the sharp edge of the point, right? Dual-eligible patients will have some challenges because of the amount that they can't pay. That 20% of healthcare costs is a lot of money to come up with, and it is going to be a problem in terms of being able to access their routine care and everyday care. But I think the more dramatic impact is going to be on services that are available in communities. I think even some outpatient facilities will close as a result. It's going to have a greater impact on the healthcare of everyone because it's going to be an access issue. Nursing Home Care Norman Ornstein, PhD: We have an enormous misunderstanding of what Medicaid is. People think it's a program for poor people, but it's far more than that. The single largest component is nursing home care. You make these cuts and nursing homes, many of which are also struggling, what are they going to do? Some will close. Others are going to cut back on the number of people serving their patients, and they're going to cut the rates at which they pay people. We are going to have people making the minimum wage, and we are going to see more and more elderly with bed sores, with abuse, and with other problems. Or we are going to see not just the elderly who use up their assets and have Medicaid to allow them to go into nursing homes, but the nightmare that families are going to have when the nursing home isn't there, and they will have to take their elderly parents or grandparents into their own homes and can't be reimbursed for any of the costs that they have or the stresses that it puts on their lives. We have a lot of issues here: the hospitals, the nursing homes. Also, we were talking before about the problems in Medicare Advantage, with prior authorization for an awful lot of people. I think it's not quite the same, but it's a little bit like these work requirements in Medicaid. The number of able-bodied people who are sitting back, cracking open a beer, and watching TV and taking their Medicaid because it doesn't cost them anything is, at best, a trace element. The tiny number of people — 3% or so — able-bodied people who are not working are taking care of other family members, or they have big health issues of their own. These work requirements are designed not to get those people working, but to take people off the Medicaid rolls because they're so complicated that people can't fill them out. They don't know what to do about them. This is going to have a devastating impact on a large number of Americans, and not just the poor. Jonathan Gruber, PhD: Let me just confirm what's been said and emphasize that three-quarters of Medicaid spending is for the elderly and disabled. Republicans want to pitch it as a program for undeserving minorities. That's not true. Almost everyone who gets Medicaid deserves it. It's a program for our moms and dads and everyone we know. We need to recognize that when Medicaid gets cut, everyone suffers. Ornstein: I just want to add one other thing that I think is important. I recently saw a documentary about the advent of the Americans with Disabilities Act, which was one of the most significant pieces of legislation to help people in this country. And it is now under siege. Jon had said, and Claudia said, disabled people are going to be devastated by this. Just yesterday [July 14] , the Supreme Court bizarrely allowed the President to go forward and cut the heart out of the Department of Education, which provides almost all of the support for students with special needs in the country. The people who are going to suffer more than anybody else in the country, other than many of the immigrants, are the disabled. And that's a problem for humanity. It is basic decency here that is under assault. That's true with a lot of these cuts in Medicaid. It's true that there will be a broader assault on people who can't care for themselves. Medicare's Influence on Independent Practice Brull: Dr Gruber, a survey of doctors by the American Medical Association in 2022 found that roughly 46% were working in practices wholly owned by physicians. The figure had fallen from 60% a decade prior. Dr Fegan, you referenced this earlier. In what ways has Medicare affected physicians' ability to remain independently owned? Gruber: I'm not sure that's been the primary driver. At the end of the day, the primary driver has been essentially the rise of the profit motivation in medicine. There's more money to be made by consolidating doctors into larger groups and specializing. That's not obviously bad; there are pros and cons of that movement, but I wouldn't say Medicare's really been a primary driver. I think the primary driver's been the fact that there's money to be made to this consolidation. The one thing to which Medicare has contributed is what I said before, which is that Medicare probably overpays subspecialists and underpays primary care. By combining them into one group, you can take advantage of that mismatch to have a more profitable overall group. Financial Uncertainty Brull: Dr Ornstein, back in 1999, the American Enterprise Institute wrote that analysts projected Medicare would reach insolvency in the following two decades, which would be now. But you also said that the first estimation of this came in the 1970s. A more recent projection from the board of trustees is 2036, so we kicked the can down a little bit. What do you think of this, and do you think it'll actually happen in the next 60 years? Ornstein: This program is so popular, for all the reasons that we know, that I just do not see Medicare becoming insolvent unless there's a deliberate attempt by those in government who want to undermine it to force insolvency. Otherwise, the closer you get, the more we're going to see fixes to make sure that the program can continue. We have seen efforts to eliminate Medicare, but they haven't gotten anywhere because of the enormous popularity of the program, for all the right reasons. So, we have to worry about it, but I'm not worried about it in the foreseeable future. Brull: Which aspects of Medicare's original mission do you think have either succeeded or fallen short, and why? Let's start with you, Dr Ornstein. Ornstein: I think the main reality here is that Medicare has saved enormous numbers of lives. It has made this country better all the way across the board. If there were no Medicare, we would have a hellscape for a large number of people — not just the elderly, but their children and their grandchildren. I would say it's also managed to deliver care pretty damned efficiently, more efficiently in many instances than the private system of insurance. There are gaps here. I think we have seen, and we continue to see, fraud because we haven't put enough resources into dealing with it, mostly on the provider side. I will just give you one very quick story. My wife has gotten from Medicare several times now a claim for a device she had nothing to do with, from a company. She spent hours on the phone with Medicare and they said, 'We know this company, it's horrible, we're going to take care of it.' Then 3 months later, we get it again and we get it a third time. We need to find more efficiencies. Gruber: I think the pros could not have been stated better by Norm. I mean, basically we would have a significantly more financially insecure country and less healthy country if Medicare didn't exist. As for the con, I would say that Medicare has not done enough to take advantage of its position as the dominant payer. There's fascinating economic research which shows that private payers often just follow what Medicare does. Pushing Health and Private Insurers Forward Gruber: Everybody talks about how the private sector is innovating, but in fact, all the innovation in medical compensation over the past 50 years has been by Medicare, and the private sector just copies them and pays X% of Medicare. I feel like Medicare could be much more innovative. Like I said, the physician reimbursement system is largely broken. Medicare could have invested a lot more — and should invest a lot more — in thinking about answering some of the hard questions we've raised today about what is the appropriate use of prior authorization, what are the appropriate rates to pay? These are important topics that Medicare should be taking the lead on understanding, experimenting with through CMMI [the Center for Medicare and Medicaid Innovation], which can run pilots, and actually trying to be much more innovative in how it sets payment policy. Fegan: I agree with both of the previous speakers. Medicare has succeeded in providing access to care to a very vulnerable population and has succeeded in providing assured compensation for the providers who take care of that population. It's one of the reasons why I've spent the past 30 years advocating for a Medicare for All that we could afford, to take care of the entire population with the program, with some improvements that we've alluded to during the discussion today. But Medicare has been a success. What it set out to do, which was to offer care and ensure that care would provide compensation for the people who delivered it — I think that we are a better society because of that. We certainly spend enough on healthcare in this country; we just fail to provide care to everyone who needs it. We allow too many people who are not engaged in the delivery of care to take profit from it. There's a lot of opportunity to address the fraud and abuse, and we just fail to do so. Part of the problem is because we have three healthcare lobbyists for every single member of Congress. Congress tends to hear those lobbyists over the cries of the public, which would really benefit from a universal healthcare system. Brull: Thank you all for joining us today and for such a productive discussion. We appreciate your time and expertise.
